Maternal anemia is a well‐recognized global health problem; however, there remain
questions on specific hemoglobin (Hb) thresholds that predict health risk or protection for …

Maternal anemia affects approximately 56 million women worldwide and increases the risk
of adverse pregnancy outcomes. Our study aimed to summarize the evidence for the …

Background Although maternal deaths are rare in developed regions, the morbidity
associated with severe postpartum hemorrhage (SPPH) remains a major problem. To …

Postpartum hemorrhage (PPH) is a leading cause of morbidity and mortality in the United
States; its prevalence increased during the 1990s–2000s. The purpose of this study was to …

Background Growing evidence suggests low and high maternal hemoglobin (Hb)
concentrations may have adverse consequences for maternal and child health. There …

Background Postpartum haemorrhage (PPH) causes substantial morbidity and mortality
worldwide. A reliable prognostic tool for PPH has potential to aid prevention efforts …

Background Postpartum hemorrhage (PPH), the leading cause of maternal death, is defined
as a blood loss> 500 mL within 24 h after vaginal delivery or> 1000 mL within 24 h after …

Postpartum hemorrhage (PPH) is a leading cause of maternal morbi-mortality. Although
obstetric risk factors are well described, the impact of predelivery hematologic and …

The increase in severe maternal morbidity and mortality in the United States correlates with
a significant rise in US cesarean birth rates from 5.5% in 1970 to a rate of 31.9% of all births …

Background Labor neuraxial analgesia may reduce the odds of postpartum hemorrhage, the
leading indication for maternal blood transfusion during childbirth. This study tested the …